[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341455-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341455-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hepatitis-b-virusmediated-m6a-demethylation-increases-hepatocellular-carcinoma-stemness-and-immune-escape","Hepatitis B Virus–Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape","","Hepatitis B virus (HBV) persistent infection drives hepatocellular carcinoma (HCC) tumorigenesis, yet how HBV-linked cancer stemness is maintained remains unclear. The study shows that HBV downregulates N6-methyladenosine (m6A) in HBV-positive HCC by enhancing ALKBH5 mRNA stability. ALKBH5 is required for stemness maintenance and self-renewal in HBV-positive but not HBV-negative HCC. Mechanistically, ALKBH5 demethylates m6A in the 3' untranslated region of SNAI2 to block YTHDF2 recognition, stabilizing SNAI2 transcripts. The ALKBH5/SNAI2 axis promotes immune evasion by upregulating the immune checkpoint ligand CD155 and identifies the ALKBH5/SNAI2/YTHDF2 pathway in stem-like phenotype and immune escape during HBV infection.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hepatitis-b-virusmediated-m6a-demethylation-increases-hepatocellular-carcinoma-stemness-and-immune-escape/341455/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hepatitis-b-virusmediated-m6a-demethylation-increases-hepatocellular-carcinoma-stemness-and-immune-escape/341455.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does HBV affect m6A modification in hepatocellular carcinoma?","Question",{"text":63,"@type":64},"HBV reduces m6A modification in HBV-positive HCC by enhancing the stability of ALKBH5 mRNA, lowering overall m6A levels.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does ALKBH5 play in cancer stemness?",{"text":68,"@type":64},"ALKBH5 is functionally required for stemness maintenance and self-renewal in HBV-positive HCC, but it is dispensable in HBV-negative HCC.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the ALKBH5/SNAI2 axis contribute to immune escape?",{"text":72,"@type":64},"The ALKBH5/SNAI2 axis accelerates tumor immune evasion through activation of the immune checkpoint ligand CD155.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341455,1790176630,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Hepatitis B Virus–Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape  \nYuting Meng1, Zheyue Shu2, Xueyao Wang3, Liang Hong1, Baohua Wang4, Jingjing Jiang1, Kangxin He1,2, Qingyi Cao1, Fan Shi1, Hai Wang5, Lan Gong6, and Hongyan Diao1  \nABSTRACT  \nHepatitis B viral (HBV) persistent infection plays a significant role in hepatocellular carcinoma (HCC) tumorigenesis. Many studies have revealed the pivotal roles of N6-methyladenosine (m6A) in multiple cancers, while the regulatory mechanism in stemness maintenance of HBV persistent infection-related HCC remains elusive. Here, we demonstrated that the level of m6A modification was downregulated by HBV in HBV-positive HCC, through enhanced stability ofALKBH5 mRNA. More specifically, we also identified that ALKBH5 mRNA was functionally required for the stemness maintenance and self-renewal in the HBV-positive HCC, but dispensable in HBV-negative HCC. Mechanistically, ALKBH5 demethylated them6A modification in the 30 untranslated region of the oncogenic gene SNAI2 to prevent the recognition of YTHDF2 therewith stabilize SNAI2 transcripts, contributing to cancer stem cell traits in HBV-positive HCC. Moreover, the expression ofSNAI2 reversed the suppression of stemness properties by knocking down ALKBH5. In addition, ALKBH5/SNAI2 axis accelerates tumor immune evasion through activated ligand of immune checkpoint CD155. Our study unveiled that the ALKBH5 induces m6A demethylation of the SNAI2 as a key regulator in HBV-related HCC, and identifies the function ofALKBH5/SNAI2/YTHDF2 axis in promoting the stemlike cells phenotype and immune escape during HBV infection.  \nImplications: HBV promotes HCC stemness maintenance through elevate m6A modification of SNAI2 in an ALKBH5-YTHDF2–dependent manner and increases the expression of the ligand of immune checkpoint CD155 .  \n􀀶  \nIntroduction  \nThe hepatocellular carcinoma (HCC) as one of the common malignancies is the fourth leading cause of tumor lethal disease worldwide (1, 2) . Hepatitis B viral (HBV) infection has been defined as a major risk factor of HCC (3–5) . Thus, clarifying the molecular mechanisms and developing the biomarkers of HBV-related HCC  \n1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P. R. China. 2Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P. R. China. 3Jinan Microecological Biomedicine Shandong Laboratory, Jinan, Shandong, P. R. China. 4Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, P. R. China. 5Department of Laboratory, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, P. R. China. 6Microbiome Research Centre, St George and Sutherland Clinical School, University of New South Wales, Sydney, New South Wales, Australia.  \nare essential to prove clinical diagnostics and benefit to precise treatment.  \nAccumulated studies revealed that cancer stem cells (CSC) maintained in HCC is the root cause of recurrence, therapy resistance, and immune escape (6–8) . HBV as the major predisposing factors for HCC has been known to trigger HCC malignancy and  \nCorresponding Author: Hongyan Diao, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Inn, The First Affiliated Hospital, Zhejiang University, Hangzhou  \n310000, Zhejiang, P. R. China. E-mail: [diaohy@zju.edu.cn](diaohy@zju.edu.cn)  \n[Mol Cancer Res 2024](Mol Cancer Res 2024);[22:642](22:642)–[5","cbCais7KnC5OO5Jd","https://ap.wps.com/l/cbCais7KnC5OO5Jd","pdf",5262712,14,"English","# Abstract\n# Introduction\n# Materials and Methods\n## Cell culture and tissue specimens","[{\"question\":\"How does HBV affect m6A modification in hepatocellular carcinoma?\",\"answer\":\"HBV reduces m6A modification in HBV-positive HCC by enhancing the stability of ALKBH5 mRNA, lowering overall m6A levels.\"},{\"question\":\"What role does ALKBH5 play in cancer stemness?\",\"answer\":\"ALKBH5 is functionally required for stemness maintenance and self-renewal in HBV-positive HCC, but it is dispensable in HBV-negative HCC.\"},{\"question\":\"How does the ALKBH5/SNAI2 axis contribute to immune escape?\",\"answer\":\"The ALKBH5/SNAI2 axis accelerates tumor immune evasion through activation of the immune checkpoint ligand CD155.\"}]","Hepatitis B Virus–Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape | PDF",1790041950,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5974336907bc455c092a83bcd65f6fec.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a222131b56c219d649c3dafb3f75b425.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5afa55cdd7cca4bb2bd53e8b0e3d437e.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1dc8fb1bbda8ac070823b657bca5dff0.webp",980,1311]